Baseline D-Dimer Levels as a Risk Assessment Biomarker for Recurrent Stroke in Patients with Combined Atrial Fibrillation and Atherosclerosis.
Kang Ho ChoiWoo-Keun SeoMan-Seok ParkJoon-Tae KimJong-Won ChungOh Young BangGeong-Moon KimTae-Jin SongBum Joon KimSung Hyuk HeoJin-Man JungKyungmi OhChi Kyung KimSungwook YuKwang Yeol ParkJeong-Min KimJong-Ho ParkJay Chol ChoiYang Ha HwangYong-Jae KimPublished in: Journal of clinical medicine (2019)
Our findings suggested that baseline D-dimer levels could be used as a risk assessment biomarker of recurrent stroke in patients with AF-related stroke and atherosclerosis. High D-dimer levels would facilitate the identification of patients who are more likely to benefit from anticoagulants to ensure secondary prevention of stroke.
Keyphrases
- atrial fibrillation
- risk assessment
- left atrial
- catheter ablation
- oral anticoagulants
- direct oral anticoagulants
- end stage renal disease
- heart failure
- cardiovascular disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- percutaneous coronary intervention
- prognostic factors
- heavy metals
- type diabetes
- cerebral ischemia
- acute coronary syndrome
- mitral valve
- coronary artery disease
- peritoneal dialysis
- climate change
- brain injury